Skip to main content
Tailor Bio is a techbio startup developing targeted therapies for cancers with Chromosomal Instability (CIN). CIN is a genomic phenomenon present in 80% of all cancers which leads to aggressive, difficult to treat cancers. Using an AI-driven platform for pan-cancer precision medicine, Tailor aims to make precision medicine a reality for some of the deadliest cancers with CIN.
CK Clinical is part of a family of science-based consultancies – The CK Group. We provide Functional Service Outsourcing services as well as helping to recruit for contract and permanent job opportunities across the UK and Europe. We aim to provide resource solutions that are tailored and cost effective to organisations ranging from small start ups to large international pharmaceutical companies. We have a track record delivering Functional Service outsourcing and contingency recruitment solutions to some of the most innovative new Biotechs right the way through to helping 9 of the top 10 major Pharma companies.
A stem cell drug discovery company
MedTech in stealth developing frozen cell sampling technologies
No data available
No data available
No data available
CCDC are world-leading experts in structural chemistry data, software and knowledge for materials and life science research and application.

They are dedicated to the advancement of chemistry and crystallography for the public benefit. They specialise in the collation, preservation and application of scientific structural data for use in pharmaceutical discovery, materials development and research and education.

CCDC compile and distribute the Cambridge Structural Database (CSD), a certified trusted database of fully curated and enhanced organic and metal-organic structures, used by researchers across the globe.

Their cutting-edge software empowers scientists to extract invaluable insights from the vast dataset, informing and accelerating their research & development.
No data available
The Institute of Cancer Research, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Scientists and clinicians at the ICR are working every day to make a real impact on cancer patients’ lives. Today, we are ranked as the UK’s leading academic research centre, and lead the world at isolating cancer-related genes and discovering new targeted cancer drugs. The ICR’s unique partnership with The Royal Marsden and ‘bench-to-bedside’ approach allows us to create and deliver results in a way that other institutions cannot.